Clinical Management of Check for Glomerular Diseases

被引:2
|
作者
Orr, Patty [1 ]
Shank, Bettina Cobb [1 ]
Hickson, Shondell [1 ]
Cooke, Jennifer [1 ]
机构
[1] Austin Peay State Univ, Sch Nursing, POB 4658, Clarksville, TN 37044 USA
关键词
Glomerulosclerosis; Focal segmental glomerulosclerosis; Diabetic nephropathy; Membranous nephropathy; Nephrotic syndrome; MEMBRANOUS NEPHROPATHY; RISK;
D O I
10.1016/j.cnur.2018.07.006
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Progressive glomerular damage can occur as a result of various etiologic factors including infections, medications, diseases, and autoimmune disorders. This article discusses the clinical management of the leading conditions associated with glomerular disease, including glomerulosclerosis, diabetic nephropathy, focal segmental glomerulosclerosis, and membranous nephropathy. Glomerular damage and disease progression may lead to end stage renal disease. Clinical management is individualized, as based on causative factors and clinical manifestations, with the overall goal of limiting glomerular damage. Collaborative and comprehensive care is imperative to improving patient outcomes.
引用
收藏
页码:551 / +
页数:18
相关论文
共 50 条
  • [21] Screening for Cancer in Patients with Glomerular Diseases
    Plaisier, Emmanuelle
    Ronco, Pierre
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (06): : 886 - 888
  • [22] Clinical and Pathophysiological Insights Into Immunological Mediated Glomerular Diseases in Childhood
    Mastrangelo, Antonio
    Serafinelli, Jessica
    Giani, Marisa
    Montini, Giovanni
    FRONTIERS IN PEDIATRICS, 2020, 8
  • [23] Treatment of Resistant Glomerular Diseases with Adrenocorticotropic Hormone Gel: A Prospective Trial
    Bomback, Andrew S.
    Canetta, Pietro A.
    Beck, Laurence H., Jr.
    Ayalon, Rivka
    Radhakrishnan, Jai
    Appel, Gerald B.
    AMERICAN JOURNAL OF NEPHROLOGY, 2012, 36 (01) : 58 - 67
  • [24] Determination of the optimal target level of proteinuria in the management of patients with glomerular diseases by using different definitions of proteinuria
    Kee, Youn Kyung
    Yoon, Chan-Yun
    Kim, Seung Jun
    Moon, Sung Jin
    Kim, Chan Ho
    Park, Jung Tak
    Lim, Beom Jin
    Chang, Tae Ik
    Kang, Ea Wha
    Kie, Jeong Hae
    Yoo, Tae-Hyun
    Jeong, Hyun Joo
    Kang, Shin-Wook
    Han, Seung Hyeok
    MEDICINE, 2017, 96 (44)
  • [25] Epidemiology and Outcomes of Glomerular Diseases in Low- and Middle-Income Countries
    Ekrikpo, Udeme
    Obiagwu, Patience
    Chika-Onu, Ugochi
    Yadla, Manjusha
    Karam, Sabine
    Tannor, Elliot K.
    Bello, Aminu K.
    Okpechi, Ikechi G.
    SEMINARS IN NEPHROLOGY, 2022, 42 (05)
  • [26] A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis
    Hartinger, Jan Miroslav
    Sima, Martin
    Hruskova, Zdenka
    Pilkova, Alena
    Kratky, Vojtech
    Rysava, Romana
    Jancova, Eva
    Bobek, Daniel
    Dousa, Jiri
    Francova, Ivana
    Tesar, Vladimir
    Slanar, Ondrej
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 175
  • [27] An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases
    Appel, Alice S.
    Appel, Gerald B.
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2009, 5 (03): : 132 - 142
  • [28] Glomerular diseases and cancer: evaluation of underlying malignancy
    Antonello Pani
    Camillo Porta
    Laura Cosmai
    Patrizia Melis
    Matteo Floris
    Doloretta Piras
    Maurizio Gallieni
    Mitchell Rosner
    Claudio Ponticelli
    Journal of Nephrology, 2016, 29 : 143 - 152
  • [29] Complement and Complement Targeting Therapies in Glomerular Diseases
    Andrighetto, Sofia
    Leventhal, Jeremy
    Zaza, Gianluigi
    Cravedi, Paolo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (24)
  • [30] Glomerular Diseases Associated With Hepatitis B and C
    Gupta, Anu
    Quigg, Richard J.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2015, 22 (05) : 343 - 351